ArticleFrontiers in pediatrics2024

Application of eculizumab, a terminal complement inhibitor, in the management of atypical hemolytic uremic syndrome in a 14-month-old Chinese pediatric patient: a case report.

Xin Wei et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.